يعرض 1 - 20 نتائج من 143 نتيجة بحث عن '"Brase, Jan C."', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المصدر: Tawbi, Hussein A; Robert, Caroline; Brase, Jan C; Gusenleitner, Daniel; Gasal, Eduard; Garrett, James; Savchenko, Alexander; Görgün, Güllü; Flaherty, Keith T; Ribas, Antoni; Dummer, Reinhard; Schadendorf, Dirk; Long, Georgina V; Nathan, Paul D; Ascierto, Paolo A (2022). Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with $\textit{BRAF}$V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i). Journal for ImmunoTherapy of Cancer, 10(6):e004226.

    وصف الملف: application/pdf

    Relation: https://www.zora.uzh.ch/id/eprint/220008/1/ZORA_e004226_full.pdf; info:pmid/35728875; urn:issn:2051-1426

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal

    المساهمون: Clinicum, Heikki Joensuu / Principal Investigator, Department of Oncology

    وصف الملف: application/pdf

    Relation: This work was supported by American Cancer Society 118813-PF-10-070-01-TBG (J.T. Garrett) and Department of Defense BC093376 (J.T. Garrett) Postdoctoral Fellowship Awards; Department of Defense Postdoctoral Fellowship Award BC103785 (A.B. Hanker); NIH/NCI K12 Award CA090625 (A.B. Hanker); NCI R01 grant CA080195 (C.L. Arteaga); NIH Breast Cancer Specialized Program of Research Excellence (SPORE) grant P50 CA98131; and Vanderbilt-Ingram Cancer Center Support Grant P30 CA68485.; Hanker , A B , Garrett , J T , Estrada , M V , Moore , P D , Ericsson , P G , Koch , J P , Langley , E , Singh , S , Kim , P S , Frampton , G M , Sanford , E , Owens , P , Becker , J , Groseclose , M R , Castellino , S , Joensuu , H , Huober , J , Brase , J C , Majjaj , S , Brohee , S , Venet , D , Brown , D , Baselga , J , Piccart , M , Sotiriou , C & Arteaga , C L 2017 , ' HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2 ' , Clinical Cancer Research , vol. 23 , no. 15 , pp. 4323-4334 . https://doi.org/10.1158/1078-0432.CCR-16-2287; ORCID: /0000-0003-0281-2507/work/39202516; http://hdl.handle.net/10138/297912; c7653f8a-fcc1-4d72-967a-40c769420287; 85027131060; 000406680300037

  13. 13
    Academic Journal

    المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer

    المصدر: Cancer discovery, Vol. 8, no.4, p. 428-443 (2018)

    Relation: boreal:219071; http://hdl.handle.net/2078.1/219071; info:pmid/29431699; urn:ISSN:2159-8274; urn:EISSN:2159-8290

  14. 14
    Electronic Resource
  15. 15
  16. 16
    Electronic Resource

    المصدر: Tawbi, Hussein A; Robert, Caroline; Brase, Jan C; Gusenleitner, Daniel; Gasal, Eduard; Garrett, James; Savchenko, Alexander; Görgün, Güllü; Flaherty, Keith T; Ribas, Antoni; Dummer, Reinhard; Schadendorf, Dirk; Long, Georgina V; Nathan, Paul D; Ascierto, Paolo A (2022). Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with $\textit{BRAF}$V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i). Journal for ImmunoTherapy of Cancer, 10(6):e004226.

  17. 17
    Electronic Resource

    المصدر: Dummer, Reinhard; Long, Georgina V; Robert, Caroline; Tawbi, Hussein A; Flaherty, Keith T; Ascierto, Paolo A; Nathan, Paul D; Rutkowski, Piotr; Leonov, Oleg; Dutriaux, Caroline; Mandalà, Mario; Lorigan, Paul; Ferrucci, Pier Francesco; Grob, Jean Jacques; Meyer, Nicolas; Gogas, Helen; Stroyakovskiy, Daniil; Arance, Ana; Brase, Jan C; Green, Steven; Haas, Tomas; Masood, Aisha; Gasal, Eduard; Ribas, Antoni; Schadendorf, Dirk (2022). Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma. Journal of Clinical Oncology, 40(13):1428-1438.

  18. 18
  19. 19
    Academic Journal
  20. 20